Showing results (61-70 of 161) with videos related to
Sort By:
Pageof 17
Current Neuropharmacology|April 22, 2021
Uncoupling Protein 2 as a Pathogenic Determinant and Therapeutic Target in Cardiovascular and Metabolic DiseasesRosita Stanzione, Maurizio Forte, Maria Cotugno, et al.High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|September 22, 2012
A survey on blood pressure levels and hypertension control in a sample of the Italian general populationMarco De Giusti, Eleonora Dito, Beniamino Pagliaro, et al.Clinical Cardiology|November 20, 2010
Prediction of long-term survival in chronic heart failure by multiple biomarker assessment: a 15-year prospective follow-up studyMassimo Volpe, Pietro Francia, Giuliano Tocci, et al.Journal of Clinical Medicine|May 9, 2020
Functional Role of Natriuretic Peptides in Risk Assessment and Prognosis of Patients with Mitral RegurgitationGiovanna Gallo, Maurizio Forte, Rosita Stanzione, et al.Nutrients|March 29, 2023
Beneficial Effects of Citrus Bergamia Polyphenolic Fraction on Saline Load-Induced Injury in Primary Cerebral Endothelial Cells from the Stroke-Prone Spontaneously Hypertensive Rat ModelRosita Stanzione, Maurizio Forte, Maria Cotugno, et al.Journal of Hypertension|March 23, 2002
Functional cross-talk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblastsPaola De Paolis, Antonio Porcellini, Carmine Savoia, et al.Journal of Molecular Histology|June 25, 2018
Cellular and subcellular localization of uncoupling protein 2 in the human kidneyMichelangelo Nigro, Claudia De Sanctis, Pietro Formisano, et al.Plos One|November 18, 2014
The C2238/αANP variant is a negative modulator of both viability and function of coronary artery smooth muscle cellsSperanza Rubattu, Simona Marchitti, Franca Bianchi, et al.ESC Heart Failure|September 8, 2025
The emerging role of Nrf2 in heart failure: From cardioprotection to therapeutic approachesEmiliano Fiori, Sergio Davinelli, Armando Ferrera, et al.Oxidative Medicine and Cellular Longevity|July 29, 2017
A Decrease of Brain MicroRNA-122 Level Is an Early Marker of Cerebrovascular Disease in the Stroke-Prone Spontaneously Hypertensive RatRosita Stanzione, Franca Bianchi, Maria Cotugno, et al.Pageof 17